The Efficacy of Potassium-competitive Acid Blocker in Patients With Laryngopharyngeal Reflux Disease
Condition: Laryngopharyngeal Reflux Disease Interventions: Drug: Tegoprazan; Drug: Placebo Sponsor: Pusan National University Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2023 Category: Research Source Type: clinical trials